Pauline Soulas-Sprauel

Pauline Soulas-Sprauel

Auto-generated profile, based on publicly available information

Pauline Soulas-Sprauel

CNRS UPR 3572 "Immunopathology and Therapeutic Chemistry"/Laboratory of Excellence Medalis, Institute of Molecular and Cellular Biology (IBMC), Strasbourg, France; Department of Clinical Immunology and Internal Medicine, National Reference Center for Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; UFR Sciences Pharmaceutiques, Université de Strasbourg, Illkirch-Graffenstaden, France

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2006 in Nature
Verified
Journal Article
Closed access
PDF file
SRStéphanie Rigaud
Stéphanie Rigaud
MFMarie-Claude Fondanèche
Marie-Claude Fondanèche
NLNathalie Lambert
Nathalie Lambert
BPBenoit Pasquier
Benoit Pasquier
VMVéronique Mateo
Véronique Mateo
SLSylvain Latour
Sylvain Latour

15 May 2008 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
PDF file
EOEric Oksenhendler
Eric Oksenhendler
LGLaurence Gérard
Laurence Gérard
CFClaire Fieschi
Claire Fieschi
MMMarion Malphettes
Marion Malphettes
GMGael Mouillot
Gael Mouillot
DGDEFI Study Group
DEFI Study Group
Background. Common variable immunodeficiency is characterized by recurrent infections and defective immunoglobulin production.

2 July 2007 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
PSPauline Soulas-Sprauel
Pauline Soulas-Sprauel
GGGwenaël Le Guyader
Gwenaël Le Guyader
PRPaola Rivera-Munoz
Paola Rivera-Munoz
VAVincent Abramowski
Vincent Abramowski
COChristelle Olivier-Martin
Christelle Olivier-Martin
JVJean-Pierre de Villartay
Jean-Pierre de Villartay
V(D)J recombination and immunoglobulin class switch recombination (CSR) are two somatic rearrangement mechanisms that proceed through the introduction of double-strand breaks (DSBs) in DNA. Although the DNA repair factor XRCC4 is essential for the resolution of DNA DSB during V(D)J recombination, its role in CSR has not been established. To bypass the embryonic lethality of XRCC4 deletion in mice, we developed a conditional XRCC4 knockout (KO) using LoxP-flanked XRCC4 cDNA lentiviral transgenesis. B lymphocyte restricted deletion of XRCC4 in these mice lead to an average two-fold reduction in CSR in vivo and in vitro. Our results connect XRCC4 and the nonhomologous end joining DNA repair pathway to CSR while reflecting the possible use of an alternative pathway in the repair of CSR DSB in the absence of XRCC4. In addition, this new conditional KO approach should be useful in studying other lethal mutations in mice.

10 December 2007 in Oncogene
Verified
Journal Article
Closed access
PSP Soulas-Sprauel
P Soulas-Sprauel
PRP Rivera-Munoz
P Rivera-Munoz
LML Malivert
L Malivert
GGG Le Guyader
G Le Guyader
VAV Abramowski
V Abramowski
JVJ-P de Villartay
J-P de Villartay

18 September 2012 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
TGthe DEFI study group
the DEFI study group
JBJean-Nicolas Boursiquot
Jean-Nicolas Boursiquot
LGLaurence Gérard
Laurence Gérard
MMMarion Malphettes
Marion Malphettes
CFClaire Fieschi
Claire Fieschi
EOEric Oksenhendler
Eric Oksenhendler

1 February 2019 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
DBDelphine Bouis
Delphine Bouis
PKPeggy Kirstetter
Peggy Kirstetter
FAFlorent Arbogast
Florent Arbogast
DLDelphine Lamon
Delphine Lamon
VDVirginia Delgado
Virginia Delgado
PSPauline Soulas-Sprauel
Pauline Soulas-Sprauel